Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis

OBJECTIVES: To evaluate radiographic progression of structural joint damage over 2 years in patients with rheumatoid arthritis from baricitinib clinical trials who were disease-modifying antirheumatic drug (DMARD)–naïve or had an inadequate response to conventional synthetic DMARDs (csDMARD-IR). MET...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:RMD Open
Main Authors: van der Heijde, Desirée, Schiff, Michael, Tanaka, Yoshiya, Xie, Li, Meszaros, Gabriella, Ishii, Taeko, Casillas, Marta, Ortmann, Robert A, Emery, Paul
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2019
Assuntos:
Rheumatoid Arthritis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6525612/
https://ncbi.nlm.nih.gov/pubmed/31168413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2019-000898
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados